International law firm Ashurst has provided legal counsel to Pure Health Holding in its acquisition of the Circle Health Group, the United Kingdom’s largest private healthcare group. Pure Health, the Middle East’s largest healthcare platform, has reached an agreement to acquire the Circle Health Group in a deal valued at AED 4.4 billion (USD 1.2 […]
Healthcare, Pharma & Life Sciences
IPOs
Saudi Arabia
Legal Advisors assists ProMedEx in its USD19.04M IPO on Nomu
Legal Advisors Abdulaziz Alajlan & Partners, in association with Baker & McKenzie Limited, has acted as legal counsel for Professional Medical Expertise Company (ProMedEx) through its initial public offering (IPO) on the Parallel Market of
Capital Markets
Healthcare, Pharma & Life Sciences
Saudi Arabia
Horizon Participation acquires into Deqh Laboratory Company
Meysan Partners’ Riyadh office advised Horizon Participation Holding, a Kuwaiti group subsidiary (“Horizon”), on acquiring a minority stake in Deqh Laboratory Company in Saudi Arabia. The acquisition will follow a scheme of arrangement under the
Healthcare, Pharma & Life Sciences
IPOs
Saudi Arabia
White & Case on Jamjoom Pharmaceuticals Factory Company IPO
Global law firm, White & Case, in collaboration with The Law Office of Megren M. Al-Shaalan, has provided legal counsel in the initial public offering (IPO) of Jamjoom Pharmaceuticals Factory Company (Jamjoom). Saudi Fransi Capital
Banking & Finance
Healthcare, Pharma & Life Sciences
Other
Clifford Chance on €45M financing of GZT Healthcare Investment
International law firm Clifford Chance advised Invest International with the EUR 45 million financing of GZT Healthcare Investment, a subsidiary of Rönesans Holding, in connection with the Gaziantep City Hospital, a public private partnership in
Deal & transactions
Healthcare, Pharma & Life Sciences
United Arab Emirates
Clifford Chance advises M42 on its acquisition of Diaverum
International law firm Clifford Chance is advising M42, an Abu Dhabi-based tech-enabled healthcare company in connection with is acquisition of the entire share capital of Diaverum from Bridgepoint Group. A transaction that will see M42
Capital Markets
Healthcare, Pharma & Life Sciences
Other
Asafo & Co.: MCP in strategic investment agreement with Laprophan
Asafo & Co. provided advisory services to Mediterrania Capital Partners (‘MCP’) as it spearheaded a consortium to execute a strategic investment agreement with Laprophan, a prominent pharmaceuticals entity in Morocco. MCP, a private equity firm
Banking & Finance
Egypt
Healthcare, Pharma & Life Sciences
B Investments and TSFE invest in Egypt’s healthcare sector
The Sovereign Fund of Egypt (“TSFE”) through its healthcare and pharmaceutical industries Subfund (“TSFE Healthcare & Pharma Subfund”) and B Investments Holding (“B Investments”), BPE Partners’ flagship investment vehicle, have signed an agreement to
Deal & transactions
Egypt
Healthcare, Pharma & Life Sciences
Sandoz Egypt Pharma signs new partnership with Ibnsina Pharma
Sandoz Egypt Pharma, a division of the Novartis Group, and Ibnsina Pharma, a pharmaceutical distribution company, have partnered to expand access to Sandoz’s over-the-counter (OTC) portfolio of products through a distribution and
Healthcare, Pharma & Life Sciences
IPOs
Other
Asafo & Co. advises in Moroccan private hospital group Akdital’s IPO
Asafo & Co. is advising Akdital in its IPO on the Casablanca Stock Exchange. The offering will take place through a capital increase and a share sale. Valued at 1.2 billion dirhams (US$ 110 million),
